A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Centre Oscar Lambret
Eli Lilly and Company
QBiotics Group Limited
M.D. Anderson Cancer Center
Hackensack Meridian Health
Rutgers, The State University of New Jersey
UNICANCER
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Institut Bergonié
Institut Bergonié
Elevation Oncology
Actuate Therapeutics Inc.
Astex Pharmaceuticals, Inc.
ImmunityBio, Inc.
Memorial Sloan Kettering Cancer Center
pharmaand GmbH
University Health Network, Toronto
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Eastern Cooperative Oncology Group
Grupo Espanol de Investigacion en Sarcomas
Amgen
Institut Bergonié
Northwestern University
UNICANCER
NYU Langone Health
Hoffmann-La Roche
MabVax Therapeutics, Inc.
Grupo de Apoio ao Adolescente e a Crianca com Cancer
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
Children's Oncology Group
Merck Sharp & Dohme LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Hoffmann-La Roche
Rocky Mountain Cancer Centers
Enzon Pharmaceuticals, Inc.
City of Hope Medical Center
Maisonneuve-Rosemont Hospital